imanova.co.uk Report : Visit Site

Technical data of the imanova.co.uk

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host imanova.co.uk. Currently, hosted in United States and its service provider is Halliburton Company .

the related websites

www1.imperial.ac.uk imperial.ac.uk hmrlondon.com rcuk.ac.uk ucl.ac.uk onenucleus.com fsl.fmrib.ox.ac.uk ft.com cbi.org.uk nhs.uk msn.com bbc.co.uk wycombeabbey.com paddypower.com milehighreport.com which.co.uk tesco.com readformyschool.co.uk 

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called Apache/2.2.15 (CentOS) containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

— navigation — solutions - clinical imaging - - imaging in clinical neuroscience and neurology - - clinical imaging core lab - nonclinical imaging - analytics - data management - ex-vivo and tissue imaging - radio and medicinal chemistry software - vivoquant™ – visualization and analysis - ipacs® – data management insight areas - translational design - therapeutic area experience - imaging informatics our approach publications - publications archives - case studies about us - careers - news - events - the team - sites and partners contact us solutions clinical imaging imaging in clinical neuroscience and neurology clinical imaging core lab nonclinical imaging analytics data management ex-vivo and tissue imaging radio and medicinal chemistry software vivoquant™ – visualization and analysis ipacs® – data management insight areas translational design therapeutic area experience imaging informatics our approach publications publications archives case studies about us careers news events the team sites and partners contact us back to news invicro has acquired imanova september 12, 2017 by kat ramey 0 comment invicro acquires imanova to expand global imaging capabilities combined business delivers world-leading imaging capabilities to drive improved decision-making from early drug discovery to late-phase clinical development boston, ma, september 12, 2017 – invicro, llc , a leading provider of imaging services and software for research and drug development, announced today the acquisition of uk-based imanova . invicro and imanova will merge all activities to establish the world’s largest provider of translational imaging services and analytics from pre-clinical development through to late-phase clinical trials. “joining forces with the phenomenal research team at imanova expands our translational, analytic and geographic offering. our groups share a common mission of improving research trials through the development and application of quantitative imaging biomarkers.” said dr. jack hoppin, invicro’s co-founder and ceo. “our combined research teams hold a collective pride in the development of novel offerings in discovery as well as the engineering of scalable, reproducible solutions for deployment in late-phase development.” imanova is a recognized world-leader in the application of pet and mr imaging, with a focus on translational research to support the transition from pre-clinical studies to phase i/ii studies in humans. the services of the combined business covers the entire translational spectrum, ranging from novel biomarker evaluation and development in early discovery to late-phase clinical trials support. “invicro develops innovative analytical approaches for clinical trials, which are highly complementary with our own. combining invicro’s and imanova’s analytics platforms means we have a best-in-class imaging informatics team to help reduce risk in drug development,” said dr. kevin cox, imanova’s ceo. “as a combined enterprise we will be a truly translational quantitative biomarker company, with an expanding late-phase clinical trial offering, able to meet the needs of a growing global market.” the addition of imanova is part of invicro’s ongoing growth strategy, to realise its mission to improve therapeutic discovery and development efforts through visualizing and quantifying biological and pathological processes in order to better diagnose, characterize, prevent, treat and, ultimately, cure disease. about invicro based in boston, ma, invicro was founded in 2008 with the mission of improving the role and function of imaging in translational drug discovery and development across all therapeutic areas. invicro’s multi-disciplinary team provides a full range of image informatics, engineering and operational services. originally focused on imaging in discovery phase, in 2016 invicro expanded its offering in clinical phase research with the acquisition of molecular neuroimaging, llc. now through preclinical and clinical divisions, invicro develops and leverages the latest approaches in imaging quantitative biomarkers. the successful integration of the discovery and clinical teams onto invicro’s industry-leading software informatics platforms, vivoquant® and ipacs®, has inspired a strong and growing presence in the market. for more information, visit www.invicro.com about imanova imanova is a translational research company that specializes in applying positron emission tomography (pet) and magnetic resonance imaging (mri) scanning techniques to improve productivity in early drug development and to help improve disease understanding. established in 2011 imanova was formed in an innovative alliance between the uk’s medical research council, imperial college london, king’s college london and university college london to act as a conduit between academia and industry. http://www.imanova.co.uk/ for more information please contact: kat ramey | sr. marketing manager t: +1 617.904.2117 e: [email protected] back to news join us for a webinar! amyloid iq an algorithm to increase power in clinical trials and automate radiological reads thursday, june 28 11:00am est presenter: prof. roger gunn, ph.d. evp, quantitative data sciences, invicro – click for more information – september 2017 m t w t f s s « aug oct » 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 news archives news archives select month june 2018 (1) may 2018 (2) march 2018 (1) february 2018 (3) january 2018 (1) october 2017 (2) september 2017 (2) august 2017 (1) july 2017 (2) june 2017 (1) april 2017 (3) march 2017 (1) february 2017 (4) january 2017 (1) november 2016 (2) october 2016 (1) september 2016 (2) august 2016 (7) july 2016 (4) june 2016 (3) may 2016 (1) april 2016 (1) march 2016 (4) february 2016 (3) january 2016 (1) december 2015 (3) november 2015 (2) october 2015 (6) september 2015 (4) august 2015 (4) july 2015 (1) june 2015 (1) may 2015 (2) april 2015 (1) march 2015 (3) february 2015 (1) december 2014 (3) november 2014 (1) october 2014 (1) september 2014 (4) august 2014 (2) july 2014 (1) april 2014 (1) march 2014 (1) february 2014 (1) december 2013 (1) november 2013 (1) august 2013 (1) june 2013 (1) april 2013 (1) october 2012 (4) search contact us: t: +1 617-904-2100 | [email protected] | 27 drydock avenue | boston, ma 02210 our policies fcoi policy privacy statement copyright (c) invicro, llc 2018 we use cookies on our website to offer you the best visitor browsing experience. you can find out more about how we use cookies and how to opt-out by clicking here . accept

URL analysis for imanova.co.uk

https://www.invicro.com/clinical-imaging/
https://www.invicro.com/contact-invicro/
https://www.invicro.com/2017/09/12/
https://www.invicro.com/imaging-informatics/
https://www.invicro.com/radiochemistry/
https://www.invicro.com/news/recentnews/
http://www.invicro.com
https://www.invicro.com/vivoquant-visualization-and-analysis/
https://www.invicro.com/2017/09/22/
https://www.invicro.com/2017/09/invicro-has-acquired-imanova/mailto:[email protected]
https://www.invicro.com/about-us/careers/
https://www.invicro.com/analytics/
https://www.invicro.com/translational-design/
https://www.invicro.com/sites-and-partners/
https://www.invicro.com/2018/06/join-us-for-a-webinar-on-amyloidiq/
imanova.co.uk

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Error for "imanova.co.uk".

the WHOIS query quota for 2600:3c03:0000:0000:f03c:91ff:feae:779d has been exceeded
and will be replenished in 438 seconds

WHOIS lookup made at 02:10:09 03-Sep-2017

--
This WHOIS information is provided for free by Nominet UK the central registry
for .uk domain names. This information and the .uk WHOIS are:

Copyright Nominet UK 1996 - 2017.

You may not access the .uk WHOIS or use any data from it except as permitted
by the terms of use available in full at http://www.nominet.uk/whoisterms,
which includes restrictions on: (A) use of the data for advertising, or its
repackaging, recompilation, redistribution or reuse (B) obscuring, removing
or hiding any or all of this notice and (C) exceeding query rate or volume
limits. The data is provided on an 'as-is' basis and may lag behind the
register. Access may be withdrawn or restricted at any time.

  REFERRER http://www.nominet.org.uk

  REGISTRAR Nominet UK

SERVERS

  SERVER co.uk.whois-servers.net

  ARGS imanova.co.uk

  PORT 43

  TYPE domain

DISCLAIMER
This WHOIS information is provided for free by Nominet UK the central registry
for .uk domain names. This information and the .uk WHOIS are:
Copyright Nominet UK 1996 - 2017.
You may not access the .uk WHOIS or use any data from it except as permitted
by the terms of use available in full at http://www.nominet.uk/whoisterms,
which includes restrictions on: (A) use of the data for advertising, or its
repackaging, recompilation, redistribution or reuse (B) obscuring, removing
or hiding any or all of this notice and (C) exceeding query rate or volume
limits. The data is provided on an 'as-is' basis and may lag behind the
register. Access may be withdrawn or restricted at any time.

  REGISTERED no

DOMAIN

  NAME imanova.co.uk

NSERVER

  NS0.PHOENIXDNS.CO.UK 212.102.192.250

  NS1.PHOENIXDNS.CO.UK 212.102.198.250

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .